Qiagen (QGEN) earnings

Earnings (net income) · fiscal 2025
$424.88M

Qiagen (QGEN) reported net income of $424.88M in fiscal 2025 (the year ended December 31, 2025). That is 408.3% higher than the $83.59M of fiscal 2024. Figures as of 18 Nov 2026, 05:25 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
$424.88M
Change on fiscal 2024
+408.3%
Growth, 5 years
+3.4% a year
Growth, 10 years
+12.6% a year
Highest on record
$512.60Mfiscal 2021
Lowest on record
-$41.46Mfiscal 2019
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Qiagen earnings, in more detail

Over the five fiscal years to 2025 net income grew at a compound 3.4% a year; over ten years the rate was 12.6% a year. Across the 18 fiscal years on record (2008–2025), the highest was $512.60M in fiscal 2021 and the lowest -$41.46M in fiscal 2019.

History · 18 fiscal years

Earnings (net income) by fiscal year

Qiagen earnings, year by year

Qiagen (QGEN) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025$424.88M 408.3% up
2024$83.59M 75.5% down
2023$341.30M 19.4% down
2022$423.21M 17.4% down
2021$512.60M 42.7% up
2020$359.19M—
2019-$41.46M 121.8% down
2018$190.38M 371.3% up
2017$40.39M 49.8% down
2016$80.40M 38.2% down
2015$130.15M 11.8% up
2014$116.37M 68.5% up
2013$69.07M 46.7% down
2012$129.51M 34.8% up
2011$96.04M 33.5% down
2010$144.31M 4.8% up
2009$137.77M 54.7% up
2008$89.03M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Qiagen and comparable companies
CompanyEarnings (net income)Fiscal year
Vaxcyte PCVX-$766.63M2025
Bio-Rad Laboratories BIO$759.90M2025
Molina Healthcare MOH$472.00M2025
Spyre Therapeutics SYRE-$155.20M2025
Qiagen QGEN$424.88M2025
Insulet PODD$247.10M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on QGEN

Qiagen, figure by figure

Qiagen (QGEN) overview: price, valuation and scorecardAll health care companies by market value

Qiagen earnings: questions and answers

What is Qiagen's net income?

Qiagen (QGEN) reported net income of $424.88M in fiscal 2025 (the year ended December 31, 2025). That is 408.3% higher than the $83.59M of fiscal 2024.

What is the growth rate of Qiagen's net income?

Over the five fiscal years to 2025 net income grew at a compound 3.4% a year; over ten years the rate was 12.6% a year.

What are the highest and lowest net income figures on record for Qiagen?

Across the 18 fiscal years on record (2008–2025), the highest was $512.60M in fiscal 2021 and the lowest -$41.46M in fiscal 2019.

How is Qiagen's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Qiagen (QGEN) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/QGEN/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.